Bharat Immunological & Biologicals Corporation Share Price
10 Aug, 2026 4:00 PM (IST)
Bharat Immunological & Biologicals Corporation Performance
- Today's Low
- ₹16
- Today's High
- ₹17
- 52 Week Low
- ₹14
- 52 Week High
- ₹23
- Open Price₹17
- Previous Close₹16
- Volume16,521
- 50 DMA₹16.60
- 100 DMA₹17.10
- 200 DMA₹18.30
Bharat Immunological & Biologicals Corporation Chart
Investment Returns
- Over 1 Month -1.81%
- Over 3 Month -16.38%
- Over 6 Month -16%
- Over 1 Year -23.96%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -3.8
- PEG Ratio
- 0
- Market Cap Cr
- 70
- P/B Ratio
- 0.8
- Average True Range
- 0.6
- EPS
- -4.3
- Dividend Yield
- 0
- MACD Signal
- -0.3
- RSI
- 45.14
- MFI
- 23.81
Latest Stock News Updates
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 16th August 2024 for General Purpose.
- BSE India
- 2 years ago
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 08th March 2024 for General Purpose.
- BSE India
- 2 years 5 months ago
Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023
- BSE India
- 2 years 7 months ago
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹16.20
- 50 Day
- ₹16.60
- 100 Day
- ₹17.10
- 200 Day
- ₹18.30
Resistance and Support
- R3 17.00
- R2 16.80
- R1 16.40
- S1 15.80
- S2 15.50
- S3 15.20
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-16 | General Purpose. | |
| 2024-03-08 | Others | General Purpose |
| 2023-10-31 | Quarterly Results | |
| 2023-04-24 | Audited Results | |
| 2023-02-09 | Quarterly Results |
About Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biolog.Corp. is engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarehha management Kit and BIB Sweet Tablets.(Source : 202303 Annual Report Page No:05) View More- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Popular Stocks
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹16 As on 10 August, 2026 | 20:11
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹70.3 Cr As on 10 August, 2026 | 20:11
The P/E ratio of Bharat Immunological & Biologicals Corporation is -3.8 As on 10 August, 2026 | 20:11
The PB ratio of Bharat Immunological & Biologicals Corporation is 0.8 As on 10 August, 2026 | 20:11
The 52 week High & Low of Bharat Immunological & Biologicals Corporation is ₹23.2/₹14.1 respectively As on 10 August, 2026 | 20:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.